TVTX Looks 57.0% Overvalued on GF Value™

gurufocus.com · 2026-09-23

On September 23, 2026, Travere Therapeutics Inc (NASDAQ: TVTX) announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent

Read the full story at gurufocus.com →